The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Hak Choy

UT Southwestern Medical Center

Dallas

Texas

USA

[email]@utsouthwestern.edu

Name/email consistency: high

[Claim this account]

Affiliations

UT Southwestern Medical Center, Dallas, Texas, USA. 2009
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9183, USA. 2004 - 2008
Vanderbilt-Ingram Cancer Center, Nashville, USA. 2003 - 2005

References

RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer. Choy, H., Jain, A.K., Moughan, J., Curran, W., Whipple, G., Demas, W.F., Ettinger, D.S. J. Thorac. Oncol (2009) [Pubmed]
Current status and future prospects for satraplatin, an oral platinum analogue. Choy, H., Park, C., Yao, M. Clin. Cancer Res. (2008) [Pubmed]
Satraplatin: an orally available platinum analog for the treatment of cancer. Choy, H. Expert. Rev. Anticancer. Ther (2006) [Pubmed]
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer. Choy, H., Nabid, A., Stea, B., Scott, C., Roa, W., Kleinberg, L., Ayoub, J., Smith, C., Souhami, L., Hamburg, S., Spanos, W., Kreisman, H., Boyd, A.P., Cagnoni, P.J., Curran, W.J. J. Clin. Oncol. (2005) [Pubmed]
Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine. Choy, H., Vokes, E. Lung. Cancer (2005) [Pubmed]
Chemoradiation in NSCLC: focus on the role of gemcitabine. Choy, H. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
Rationale for investigation of epidermal growth factor receptor inhibitors in definitive treatment of locally advanced non-small cell lung cancer and head and neck cancer. Choy, H., Kim, D.W. Semin. Respir. Crit. Care. Med (2004) [Pubmed]
Locally advanced NSCLC: current state of the art, treatment and future directions. Choy, H., Bonomi, P.D. J. Natl. Compr. Canc. Netw (2004) [Pubmed]
Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?. Choy, H., Milas, L. J. Natl. Cancer Inst. (2003) [Pubmed]